Ceryvyn Therapeutics Limited

CKDXF ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Feb 24, 2021 6-K
424B3 Feb 22, 2021 424B3
6-K Feb 22, 2021 6-K
6-K Feb 17, 2021 6-K
SC 13G Feb 16, 2021 SC 13G
SC 13G/A Feb 10, 2021 AMENDMENT NO. 1
6-K Jan 19, 2021 6-K
6-K Dec 17, 2020 6-K
S-8 Dec 1, 2020 S-8
SC 13G Nov 12, 2020
6-K Oct 27, 2020 6-K
6-K Oct 21, 2020 6-K
424B4 Oct 19, 2020 424B4
EFFECT Oct 16, 2020
SEC STAFF LETTER Oct 15, 2020
CORRESP Oct 15, 2020
CORRESP Oct 15, 2020
CERT Oct 15, 2020 8A CERT
F-1/A Oct 15, 2020 F-1/A
8-A12B Oct 14, 2020 8-A12B
CORRESP Oct 9, 2020
F-1/A Oct 9, 2020 F-1/A
UPLOAD Oct 5, 2020
F-1 Sep 24, 2020 F-1
SEC STAFF LETTER Sep 16, 2020
← Newer Page 8 of 9 · 204 filings Older →